The Cira™ immunoassay platform was specifically designed by a team of Aushon engineers and biologists to offer accurate multiplex biomarker analysis with simplicity and savings in mind. The Cira™ platform combines the accuracy and precision of ELISA, the sensitivity of chemiluminescence, and the throughput and affordability of multiplexing. The circular Ciraplex® format (patent-pending) offers enhanced accuracy and precision versus traditional protein array configurations. The Aushon menu features key biomarkers in a wide range of therapeutic areas being used to enhance knowledge and improve decision-making in translational medicine.

May 3, 2017 — Dr. Andrew Nixon scheduled to present Use of Ultra-Sensitive Multiplex Protein Arrays in Immuno-Oncology Biomarker Development at the 2017 Biomarkers & Immuno-Oncology World Congress. Read More

May 19, 2016 — Genome Web Publishes Article on Aushon's move into the ultrasensitive immunoassay space through the development of a series of cytokine assays that can achieve sensitivity in the femtogram per ml range. Read More